Cancers 2011, 3(1), 883-896; doi:10.3390/cancers3010883
Review

Components of Cell-Matrix Linkage as Potential New Markers for Prostate Cancer

Center for Molecular Medicine, Deptartment Vascular Matrix Biology, Excellence Cluster Cardio-Pulmonary System, Frankfurt University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
* Author to whom correspondence should be addressed.
Received: 25 January 2011; in revised form: 12 February 2011 / Accepted: 17 February 2011 / Published: 25 February 2011
(This article belongs to the Special Issue Organ-Specific Metastasis Formation)
PDF Full-text Download PDF Full-Text [344 KB, uploaded 25 February 2011 10:08 CET]
Abstract: Prostate cancer is one of the most common tumor diseases worldwide. Often being non-aggressive, prostate tumors in these cases do not need immediate treatment. However, about 20% of diagnosed prostate cancers tend to metastasize and require treatment. Existing diagnostic methods may fail to accurately recognize the transition of a dormant, non-aggressive tumor into highly malignant prostate cancer. Therefore, new diagnostic tools are needed to improve diagnosis and therapy of prostate carcinoma. This review evaluates existing methods to diagnose prostate carcinoma, such as the biochemical marker prostate-specific antigen (PSA), but also discusses the possibility to use the altered expression of integrins and laminin-332 in prostate carcinomas as diagnostic tools and therapeutic targets of prostate cancer.
Keywords: prostate cancer; laminins; integrins; proteases; diagnosis

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Navdaev, A.; Eble, J.A. Components of Cell-Matrix Linkage as Potential New Markers for Prostate Cancer. Cancers 2011, 3, 883-896.

AMA Style

Navdaev A, Eble JA. Components of Cell-Matrix Linkage as Potential New Markers for Prostate Cancer. Cancers. 2011; 3(1):883-896.

Chicago/Turabian Style

Navdaev, Alexey; Eble, Johannes A. 2011. "Components of Cell-Matrix Linkage as Potential New Markers for Prostate Cancer." Cancers 3, no. 1: 883-896.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert